These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29538049)

  • 1. The importance of specific rehabilitation for an obese patient with idiopathic intracranial hypertension: a case report.
    Raggi A; Grazzi L; Bianchi Marzoli S; Ciasca P; Chiapparini L; Erbetta A; Faragò G; Leonardi M; D'Amico D
    Int J Rehabil Res; 2018 Jun; 41(2):183-185. PubMed ID: 29538049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing idiopathic intracranial hypertension in the eye clinic.
    Bonelli L; Menon V; Arnold AC; Mollan SP
    Eye (Lond); 2024 Aug; 38(12):2472-2481. PubMed ID: 38789788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
    JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri).
    Johnson LN; Krohel GB; Madsen RW; March GA
    Ophthalmology; 1998 Dec; 105(12):2313-7. PubMed ID: 9855165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV; Friedman DI
    Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of idiopathic intracranial hypertension].
    Wang YH; Ma J; Zhong Y
    Zhonghua Yan Ke Za Zhi; 2016 Dec; 52(12):948-951. PubMed ID: 27998460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
    Wall M; Thurtell MJ;
    Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unilateral papilledema in pseudotumor cerebri.
    Brosh K; Strassman I
    Semin Ophthalmol; 2013 Jul; 28(4):242-3. PubMed ID: 23627435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and Weight Loss in Idiopathic Intracranial Hypertension: A Narrative Review.
    Subramaniam S; Fletcher WA
    J Neuroophthalmol; 2017 Jun; 37(2):197-205. PubMed ID: 27636748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudotumor cerebri: yet another reason to fight obesity.
    Stevenson SB
    J Pediatr Health Care; 2008; 22(1):40-3. PubMed ID: 18174088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight loss, acetazolamide, and pseudotumor cerebri.
    Pomeranz HD
    Ophthalmology; 1999 Sep; 106(9):1639. PubMed ID: 10485520
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of idiopathic intracranial hypertension by endovascular improvement of venous drainage of the brain].
    Aguilar-Pérez M; Henkes H
    Ophthalmologe; 2015 Oct; 112(10):821-7. PubMed ID: 26400795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.
    Samara A; Ghazaleh D; Berry B; Ghannam M
    J Med Case Rep; 2019 Apr; 13(1):94. PubMed ID: 30999940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Headache and diplopia in an extremely obese adolescent].
    Sousa Gd; Baatz H; Aksu F; Wunsch R; Reinehr T
    Klin Padiatr; 2008; 220(5):316-7. PubMed ID: 18651375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update of idiopathic intracranial hypertension.
    Madriz Peralta G; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudotumor cerebri syndrome].
    Rüther K
    Ophthalmologe; 2014 Apr; 111(4):383-94. PubMed ID: 24756190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic intracranial hypertension: is papilloedema inevitable?
    Wraige E; Chandler C; Pohl KR
    Arch Dis Child; 2002 Sep; 87(3):223-4. PubMed ID: 12193432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol.
    Ottridge R; Mollan SP; Botfield H; Frew E; Ives NJ; Matthews T; Mitchell J; Rick C; Singhal R; Woolley R; Sinclair AJ
    BMJ Open; 2017 Sep; 7(9):e017426. PubMed ID: 28963303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease.
    Villain MA; Pageaux GP; Veyrac M; Arnaud B; Harris A; Greenfield DS
    Am J Ophthalmol; 2002 Nov; 134(5):778-80. PubMed ID: 12429264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudotumor cerebri in pediatric age: role of obesity in the management of neurological impairments.
    Marton E; Feletti A; Mazzucco GM; Longatti P
    Nutr Neurosci; 2008 Feb; 11(1):25-31. PubMed ID: 18510800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.